Dear colleague,

You are cordially invited to submit a manuscript to the Journal of Pharmacy & Pharmacognosy Research (JPPRes) (ISSN 0719-4250), an international, bimonthly specialized and peer-reviewed open access journal devoted to the publication of original contributions in relevant areas, which publishes original research articles, reviews, letters and guest edited single topic issues in all areas of Pharmacy and Pharmacognosy in English or Spanish.

Papers of JPPRes are opening accessible at the journal’s homepage: http://jppres.com/jppres, and you are invited to read or download them freely for the academic exchanges.

The Audience of JPPRes could be: Biochemists, Biotechnologists, Botanists, Chemical Engineers, Clinical Pharmacologists, Medical Scientists, Medicinal Chemists, Natural Product Chemists, Pharmaceutical Scientists, Pharmacologists, Pathologists, Plant Scientists, and Toxicologists, among others.

Frequency of publication: Electronic versions of articles are published immediately and continuously once the manuscripts have been accepted. JPPRes has an acceptance rate of 16.6% (2019). The average time between submission and final decision is 70 days and the average time between acceptance and final publication is 15 days. JPPRes does not charge any fee for authors submitting manuscripts. However, an article-processing charge (APC) of 250 USD (US Dollars) applies to papers accepted after peer review.

You are welcome to submit your manuscript to this journal: editor@jppres.com or jppres12@gmail.com

Please, visit the Author Guidelines, Submit an Article or contact us if you have any questions about the journal.

Best regards,

Prof. Gabino Garrido
Editor in Chief

FIND ISSUES: In Progress Issue: Volume 10, Issue 2 (Mar-Apr), 2022 2022
Current Issue: Volume 10, Issue 1 (Jan-Feb), 2022

Volume 9, Issue 6 (Nov-Dec), 2021

Volume 9, Issue 5 (Sep-Oct), 2021

Recently Published Issues: 2020 2019
2018 2017
2016 2015
2014  2013
Indexed in: 
Master Journal List CiteScore

SCImago Journal & Country Rank

Last Update: October 14, 2021